d-alpha tocopherol has been researched along with Cognition Disorders in 103 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (6.80) | 18.2507 |
| 2000's | 64 (62.14) | 29.6817 |
| 2010's | 32 (31.07) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auinger, P; Christine, CW; Green, R; Joslin, A; Yelpaala, Y | 1 |
| Abraham, RP; Al-Assaf, AS; Chong, LY; Denton, DA; Di Nisio, M; Griffith, DJ; Malik, MA; Martínez, G; McCleery, J; Rafeeq, S; Rutjes, AW; Tabet, N; Vernooij, RW; Yaman, H | 1 |
| Biesalski, HK; Dismar, S; Ludolph, AC; Noeth, N; Ott-Renzer, CS; von Arnim, CA | 1 |
| Auinger, P; Cain, KC; Cholerton, B; Ginghina, C; Liu, C; Shi, M; Stewart, T; Zhang, J | 1 |
| Bechtel, C; Doshanjh, L; Fishman, P; Larsen, D; Luo, Y; Morrell, C; Page, R; Remington, R; Samar, A; Shea, TB; Smyers, K | 1 |
| Chen, HL; Wang, CH; Wu, WT; Yen, CH | 1 |
| Bechtel, C; Larsen, D; Morrell, C; Page, R; Remington, R; Samar, A; Shea, TB | 1 |
| Bishnoi, M; Chopra, K; Kuhad, A; Tiwari, V | 1 |
| Anlasik, T; Aust, O; Mang, N; Mangialasche, F; Mariani, E; Mecocci, P; Nelles, G; Pientka, L; Polidori, MC; Praticó, D; Sies, H; Stahl, W | 1 |
| Hagihara, Y; Ishida, N; Iwahashi, H; Niki, E; Shichiri, M; Tamai, H; Yoshida, Y | 1 |
| Chen, J; Grodstein, F; Willett, WC | 1 |
| Kim, HC; Nabeshima, T; Nabeshima, Y; Nagai, T; Noda, Y; Yamada, K | 1 |
| Douglas, JA; Farrell, PM; Koscik, RL; Kosorok, MR; Lai, HJ; Laxova, A; Rock, MJ; Splaingard, ML; Zaremba, KM | 1 |
| Mester, NV; Volchegorskiĭ, IA; Zotova, OG | 1 |
| Banks, S; Dunn, JE; Stoddard, AM; Weintraub, S | 1 |
| Ge, H; Li, W; Sun, B; Sun, H; Yin, Y; Zhang, X | 1 |
| Cervera-Ferri, A; Esteve, D; Lloret, A; Monllor, P | 1 |
| Gao, J; Gräff, J; Kahn, M; Ota, KT; Rei, D; Samiei, A; Tsai, LH | 1 |
| Dilis, V; Rafnsson, SB; Trichopoulou, A | 1 |
| Auinger, P; Cain, KC; Cholerton, B; Ginghina, C; Liu, C; Shi, M; Zhang, J | 1 |
| Bueno-de-Mesquita, HB; Milder, IE; Nooyens, AC; van Boxtel, MP; van Gelder, BM; Verschuren, WM | 1 |
| Krause, D; Roupas, P | 1 |
| Karamian, R; Komaki, A; Nazari, M; Salehi, I; Sarihi, A; Shahidi, S; Taheri, M; Tahmasebi, L | 1 |
| Fukui, K; Hirano, A; Nakamura, K; Shirai, M; Takatsu, H; Urano, S | 1 |
| Tucker, KL | 1 |
| Kosaka, H; Murata, T; Takahashi, T; Wada, Y; Yoneda, M | 1 |
| Baldeiras, I; Duro, D; Garrucho, MH; Oliveira, CR; Pascoal, R; Proença, MT; Rodrigues, A; Santana, I | 1 |
| Barkhof, F; DeCarli, C; Harvey, D; Jack, CR; Petersen, RC; Scheltens, P; Thal, LJ; van Straaten, EC | 1 |
| Chow, CK | 1 |
| Aisen, PS; Ascherio, A; Becerra, LM; Irizarry, MC; Peterson, RC; Raman, R; Schwarzschild, MA; Thomas, RG | 1 |
| Breteler, MM; Devore, EE; Grodstein, F; Hu, FB; Kang, JH; Okereke, O; Rosner, B; Stampfer, MJ | 1 |
| Albert, CM; Buring, JE; Cook, NR; Grodstein, F; Kang, JH; Manson, JE | 1 |
| Dysken, MW; Kirk, LN; Kuskowski, M | 1 |
| Ansari, MA; Hoda, MN; Ishrat, T; Islam, F; Khan, MB; Parveen, K; Saleem, S; Yousuf, S | 1 |
| Fu, XF; Luo, HB; Shi, XQ; Yang, JS; Yang, QD | 1 |
| Comin, D; de Oliveira, RM; Gazarini, L; Milani, H; Zanoni, JN | 1 |
| Aisen, PS; Apostolova, LG; Cummings, JL; Decarli, CS; Green, AE; Harvey, DJ; Hwang, KS; Jack, CR; Petersen, RC; Thal, LJ; Thompson, PM; Toga, AW; Zoumalan, C | 1 |
| Mousa, SA; Usoro, OB | 1 |
| Aisen, PS; Emond, J; Fleisher, AS; Petersen, RC; Raman, R; Sherzai, A; Whitehair, DC | 1 |
| Aydin, H; Cetin, E; Ozkaya, YG; Sahin, G; Top, EC; Toraman, F | 1 |
| Barnes, LL; Bennett, DA; Christov, A; Hensley, K; Honer, WG; Morris, MC; Schneider, JA; Tangney, C | 1 |
| Bossù, P; Caltagirone, C; Gianni, W; Iuliano, L; Monticolo, R; Spalletta, G; Spoletini, I; Straface, G | 1 |
| Dalmaz, C; Ferreira, AG; Machado, FR; Scherer, EB; Tagliari, B; Wyse, AT | 1 |
| Morris, MC | 1 |
| Andreeva, VA; Ferry, M; Galan, P; Hercberg, S; Jeandel, C; Kesse-Guyot, E | 1 |
| Heim, L; Jaceldo-Siegl, K; Perez, L; Sherzai, A | 1 |
| Pan, T; Zhang, Y; Zhong, M; Zhong, X; Zhu, D | 1 |
| Devore, EE; Grodstein, F; Kang, JH; Stampfer, MJ | 1 |
| Bienias, JL; Evans, DA; Morris, MC; Tangney, CC; Wilson, RS | 1 |
| Meydani, M | 2 |
| Joseph, J; Martin, A; Shukitt-Hale, B; Szprengiel, A; Youdim, K | 1 |
| Allain, H; Belliard, S; Bentue-Ferrer, D; Djemaï, M; Merienne, M; Reymann, JM | 1 |
| Brenner, SR | 1 |
| Catani, M; Cecchetti, R; Cherubini, A; Mariani, E; Mattioli, P; Mecocci, P; Metastasio, A; Polidori, MC; Rinaldi, P; Senin, U | 1 |
| Sano, M | 1 |
| Hatakeyama, Y; Nakano, N; Yoshida, T | 1 |
| Kumar, R; Mihalick, SM; Ortiz, D; Rogers, E; Shea, TB | 1 |
| Mecocci, P | 1 |
| Conte, V; Fujimoto, S; Lee, VM; Longhi, L; McIntosh, TK; Praticò, D; Rokach, J; Trojanowski, JQ; Uryu, K; Yao, Y | 1 |
| Foote, RL; Frytak, S; Jatoi, A; Kahanic, SP; Petersen, RC; Schaefer, P; Sloan, J | 1 |
| Clemons, TE; Lindblad, AS; McBee, WL; Yaffe, K | 1 |
| Artz, M; Fillenbaum, GG; Gray, SL; Hanlon, JT; Landerman, LR; Schmader, KE | 1 |
| Breteler, MM; Engelhart, MJ; Hofman, A; Kiliaan, A; Meijer, J; Ruitenberg, A; van Swieten, JC; Witteman, JC | 1 |
| Andres-Lacueva, C; Bartali, B; Cherubini, A; Corsi, A; Di Iorio, A; Ferrucci, L; Lamponi, M; Martin, A; Mecocci, P; Senin, U | 1 |
| Bennett, D; Doody, R; Ferris, S; Galasko, D; Grundman, M; Jin, S; Kaye, J; Levey, A; Petersen, RC; Pfeiffer, E; Sano, M; Thal, LJ; Thomas, RG; van Dyck, CH | 1 |
| Blacker, D | 1 |
| Basran, J; Ebly, EM; Hicks, MS; Hogan, DB; Maxwell, CJ | 1 |
| Marder, K | 1 |
| Kolosova, NG; Loskutova, LV; Sergeeva, SV; Shcheglova, TV | 1 |
| Jelic, V; Kivipelto, M; Winblad, B | 1 |
| Benton, D; Kallus, KW; Schmitt, JA | 1 |
| Abe, K; Fukui, K; Shinkai, T; Suzuki, S; Takatsu, H; Urano, S | 1 |
| Ownby, RL | 1 |
| Tariot, PN | 1 |
| Canu, E; Frisoni, GB; Geroldi, C; Zacchi, V; Zanetti, O | 1 |
| Clark, CM; DeCarli, C; Frisoni, GB; Grundman, M; Harvey, D; Jack, CR; Jin, S; Petersen, RC; Scheltens, P; Thal, LJ | 1 |
| Fleisher, AS; Gamst, AC; Petersen, RC; Sowell, BB; Taylor, C; Thal, LJ | 1 |
| Ames, D; Ritchie, C | 1 |
| Gagnon, E; Robinson, B; Small, BJ | 1 |
| Doody, RS; Gamst, A; Grundman, M; Jack, CR; Jin, S; Petersen, RC; Sencakova, D; Thal, LJ; Ward, CP | 1 |
| Ancelin, ML; Christen, Y; Ritchie, K | 1 |
| Yaffe, K | 1 |
| Cecchetti, R; Forti, P; Lucicesare, A; Mangialasche, F; Mecocci, P; Patterson, C; Pisacane, N; Ravaglia, G; Rietti, E | 1 |
| Brady, J; Carter, J; Como, P; Growdon, J; Huber, S; Kanigan, B; Kieburtz, K; Landow, E; McDermott, M; Rudolph, A | 1 |
| Bermejo, F; del Ser, T; Fernández-Calle, P; Herranz, A; Jiménez-Jiménez, FJ; Molina, JA; Ortuño, B; Sainz, MJ; Villanueva, C | 1 |
| Perrig, P; Perrig, WJ; Stähelin, HB | 1 |
| Berr, C; Bonithon-Kopp, C; Richard, MJ; Roussel, AM | 1 |
| Bickford, PC; Cao, G; Denisova, NA; Joseph, JA; Martin, A; Prior, RL; Shukitt-Hale, B; Taglialatela, G | 1 |
| Karlawish, JH; Whitehouse, PJ | 1 |
| Grundman, M | 1 |
| Folsom, AR; Goff, DC; Knopman, DS; Mosley, TH; Peacock, JM; Szklo, M | 1 |
| Alpérovitch, A; Arnaud, J; Balansard, B; Berr, C; Roussel, AM | 1 |
| Chen, GG; Doraiswamy, PM; McLendon, BM | 1 |
| Dreon, DM; Peroutkal, SJ | 1 |
| Cummings, JL; Cyrus, PA; Masterman, D; Nadel, A | 1 |
| Tangney, CC | 1 |
24 review(s) available for d-alpha tocopherol and Cognition Disorders
| Article | Year |
|---|---|
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Ascorbic Acid; Cognition; Cognition Disorders; Dementia; Dietary Supplements; Executive Function; Humans; Memory, Episodic; Middle Aged; Mortality; Picolinic Acids; Quality of Life; Randomized Controlled Trials as Topic; Trace Elements; Vitamin B Complex; Vitamins | 2018 |
[Cognition impairment in the klotho gene mutant mice and oxidative stress].
Topics: Aging; alpha-Tocopherol; Animals; Antioxidants; Apoptosis; Cognition Disorders; Disease Models, Animal; Glucuronidase; Hippocampus; Humans; Klotho Proteins; Lipid Peroxidation; Membrane Proteins; Mice; Mice, Mutant Strains; Mutation; Oxidative Stress | 2003 |
The Effectiveness of Vitamin E Treatment in Alzheimer's Disease.
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognition Disorders; Humans; Oxidative Stress; Treatment Outcome; Vitamin E | 2019 |
Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies.
Topics: Aged; Antioxidants; Ascorbic Acid; Carotenoids; Cognition; Cognition Disorders; Databases, Factual; Diet; Flavonoids; Humans; Meta-Analysis as Topic; Observational Studies as Topic; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2013 |
Effect of Vitamin Intake on Cognitive Decline in Older Adults: Evaluation of the Evidence.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cognition; Cognition Disorders; Dementia; Dietary Supplements; Folic Acid; Homocysteine; Humans; Meta-Analysis as Topic; Vitamin A; Vitamin B 12; Vitamin B 6; Vitamin D; Vitamin D Deficiency; Vitamin E; Vitamins | 2015 |
Nutrient intake, nutritional status, and cognitive function with aging.
Topics: Aging; Animals; Antioxidants; Brain; Cognition; Cognition Disorders; Energy Intake; Fatty Acids, Omega-3; Humans; Nutritional Status; Vitamin B Complex; Vitamin D; Vitamin E | 2016 |
Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences.
Topics: Alzheimer Disease; Antioxidants; Cognition Disorders; Humans; Vitamin E | 2010 |
Nutritional determinants of cognitive aging and dementia.
Topics: Aging; Animals; Cognition Disorders; Dementia; Diet; Dietary Fats; Docosahexaenoic Acids; Folic Acid; Humans; Vitamin B 12; Vitamin E; Vitamins | 2012 |
Nutrition and vascular dementia.
Topics: Animals; Antioxidants; Ascorbic Acid; Cholesterol; Cognition Disorders; Dementia, Vascular; Diet; Disease Progression; Fishes; Folic Acid; Humans; Meat; Nutritional Status; Prevalence; Risk Factors; Vitamin B 12; Vitamin E | 2012 |
Roles of vitamins E and C on neurodegenerative diseases and cognitive performance.
Topics: Aged; Antioxidants; Ascorbic Acid; Cognition; Cognition Disorders; Female; Humans; Male; Middle Aged; Neurodegenerative Diseases; Vitamin E | 2002 |
[Mild Cognitive Impairment: potential therapeutics].
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Dopamine Agonists; Humans; Indans; Neuropsychological Tests; Piperidines; Severity of Illness Index; Vitamin E | 2002 |
Noncholinergic treatment options for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Anticholesteremic Agents; Antioxidants; Behavioral Symptoms; Clinical Trials as Topic; Cognition Disorders; Estrogens; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Middle Aged; Patient Selection; Research Design; Selegiline; Vitamin E | 2003 |
[Mild cognitive impairment].
Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Disease Progression; Humans; Psychiatric Status Rating Scales; Selegiline; Severity of Illness Index; Vitamin E | 2003 |
Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum.
Topics: Aged; Alzheimer Disease; Ascorbic Acid; Cognition Disorders; Erythrocytes; Humans; Oxidative Stress; Vitamin A; Vitamin E | 2004 |
Clinical trials in mild cognitive impairment: lessons for the future.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Lactones; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index; Sulfones; Vitamin E | 2006 |
How should we measure nutrition-induced improvements in memory?
Topics: Aged; Aging; Cognition; Cognition Disorders; Dementia; Humans; Memory; Mental Recall; Neuropsychological Tests; Nutritional Physiological Phenomena; Phosphatidylserines; Vitamin E | 2005 |
Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; Neuroprotective Agents; Nursing Homes; Patient Transfer; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Selegiline; Severity of Illness Index; Treatment Outcome; Vitamin E | 2006 |
Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
Topics: Adult; Alzheimer Disease; Cognition Disorders; Disease Progression; Donepezil; Humans; Indans; Neuropsychological Tests; Nootropic Agents; Piperidines; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Time Factors; Vitamin E | 2007 |
Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cognition Disorders; Flavonoids; Humans; Reactive Oxygen Species; Superoxide Dismutase; Vitamin E; Wine | 2007 |
Is the placebo control obsolete in a world after donepezil and vitamin E?
Topics: Cognition Disorders; Control Groups; Controlled Clinical Trials as Topic; Donepezil; Ethics Committees, Research; Ethics, Medical; Federal Government; Government Regulation; Humans; Indans; Piperidines; Placebos; Research Design; Research Subjects; Risk Assessment; Therapeutic Human Experimentation; Vitamin E | 1998 |
Vitamin E and Alzheimer disease: the basis for additional clinical trials.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Clinical Trials as Topic; Cognition Disorders; Humans; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Oxidative Stress; Selegiline; Vitamin E | 2000 |
Antioxidants and cognitive function.
Topics: Aged; Aging; Animals; Antioxidants; Ascorbic Acid; beta Carotene; Cognition; Cognition Disorders; Humans; Oxidative Stress; Vitamin E | 2001 |
Does vitamin E protect against cognitive changes as we age?
Topics: Aged; Aging; Animals; Biomarkers; Cognition; Cognition Disorders; Humans; Models, Animal; Vitamin E | 2001 |
New tools for taking control of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Humans; Practice Guidelines as Topic; Risk Factors; Vitamin E | 2001 |
23 trial(s) available for d-alpha tocopherol and Cognition Disorders
| Article | Year |
|---|---|
Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease.
Topics: alpha-Tocopherol; Antioxidants; Antiparkinson Agents; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Predictive Value of Tests; Selegiline; Treatment Outcome; Vitamin B 12 | 2018 |
Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.
Topics: Adult; Aged; Aged, 80 and over; alpha-Synuclein; alpha-Tocopherol; Antiparkinson Agents; Cognition Disorders; Cohort Studies; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Selegiline | 2014 |
A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Caregivers; Cognition Disorders; Cohort Studies; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Humans; Male; Middle Aged; Mood Disorders; Time Factors; Vitamin B 12 | 2015 |
Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Cognition Disorders; Dietary Supplements; Disease Progression; Female; Folic Acid; Follow-Up Studies; Humans; Male; Mood Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Time Factors; Vitamin B 12 | 2016 |
A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration.
Topics: Analysis of Variance; Animals; Atrophy; Brain; Caloric Restriction; Case-Control Studies; Cognition Disorders; Cyclin-Dependent Kinase 5; Disease Models, Animal; Double-Blind Method; Excitatory Postsynaptic Potentials; Female; Green Fluorescent Proteins; Immunoprecipitation; In Vitro Techniques; Long-Term Potentiation; Male; Memory Disorders; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Nerve Tissue Proteins; Neurodegenerative Diseases; Phosphopyruvate Hydratase; Phosphotransferases; Piperidines; Silver Staining; Sirtuin 1; Synapses; Thiazoles; Tumor Suppressor Protein p53; Vitamin E | 2013 |
CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.
Topics: Adult; Aged; Amyloid beta-Peptides; Antioxidants; Apolipoproteins E; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Female; Humans; Linear Models; Male; Middle Aged; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Parkinson Disease; Peptide Fragments; Predictive Value of Tests; Selegiline; Severity of Illness Index; tau Proteins; Time Factors; Vitamin E | 2015 |
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Antioxidants; Atrophy; Brain; Cerebral Ventricles; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Disease Progression; Donepezil; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Piperidines; Prospective Studies; Temporal Lobe; Time Factors; Treatment Outcome; Vitamin E | 2008 |
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study.
Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cognition Disorders; Female; Follow-Up Studies; Humans; Memory Disorders; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Oxidative Stress; Risk Factors; Single-Blind Method; Treatment Failure; Vitamin E | 2009 |
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
Topics: Aged; Alzheimer Disease; Atrophy; Cognition Disorders; Disease Progression; Female; Follow-Up Studies; Functional Laterality; Hippocampus; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nootropic Agents; Severity of Illness Index; Vitamin E | 2010 |
Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people.
Topics: Aged; Aged, 80 and over; Antioxidants; Cognition; Cognition Disorders; Dietary Supplements; Exercise; Humans; Middle Aged; Vitamin E; Walking | 2010 |
A healthy dietary pattern at midlife is associated with subsequent cognitive performance.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cognition; Cognition Disorders; Energy Metabolism; Feeding Behavior; Female; Follow-Up Studies; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Selenium; Verbal Learning; Vitamin E; Vitamins; Zinc | 2012 |
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Apolipoproteins E; Ascorbic Acid; Carotenoids; Cognition Disorders; Erythrocytes; Female; Glutathione Peroxidase; Humans; Male; Matched-Pair Analysis; Oxidative Stress; Plasma; Reference Values; Superoxide Dismutase; Uric Acid; Vitamin A; Vitamin E | 2003 |
Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.
Topics: Aged; Antioxidants; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Double-Blind Method; Female; Humans; Indans; Lung Neoplasms; Male; Piperidines; Vitamin E | 2005 |
Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cognition Disorders; Copper; Female; Humans; Male; Middle Aged; Vitamin E; Zinc | 2004 |
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Double-Blind Method; Humans; Indans; Nootropic Agents; Piperidines; Proportional Hazards Models; Treatment Failure; Vitamin E | 2005 |
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Topics: Aged; Cholinesterase Inhibitors; Cognition Disorders; Confidence Intervals; Donepezil; Double-Blind Method; Female; Humans; Indans; Male; Neuropsychological Tests; Piperidines; Retrospective Studies; Treatment Outcome; Vitamin E | 2005 |
Donepezil and vitamin E for mild cognitive impairment.
Topics: Alzheimer Disease; Cognition Disorders; Donepezil; Humans; Indans; Long-Term Care; Piperidines; Treatment Outcome; Vitamin E | 2006 |
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.
Topics: Aged; Aged, 80 and over; Atrophy; Cognition Disorders; Dementia; Disease Progression; Donepezil; Double-Blind Method; Female; Humans; Indans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Nootropic Agents; Piperidines; Predictive Value of Tests; Reproducibility of Results; Temporal Lobe; Vitamin E | 2007 |
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Antioxidants; Apolipoprotein E4; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Disease Progression; Donepezil; Female; Genotype; Humans; Indans; Linear Models; Male; Neuropsychological Tests; Piperidines; Placebo Effect; Predictive Value of Tests; Prognosis; Sex Distribution; Vitamin E | 2007 |
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.
Topics: Aged; Aged, 80 and over; Antioxidants; Atrophy; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Female; Hippocampus; Humans; Incidence; Indans; Longitudinal Studies; Male; Middle Aged; Piperidines; Treatment Outcome; United States; Vitamin E | 2008 |
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.
Topics: Aged; Cognition Disorders; Female; Humans; Male; Middle Aged; Parkinson Disease; Selegiline; Vitamin E | 1994 |
Vitamin E drug.
Topics: AIDS Dementia Complex; Antioxidants; Cognition Disorders; Free Radical Scavengers; HIV Infections; Humans; Indans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Vitamin E | 1995 |
Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Anxiety; Apolipoproteins E; Behavior; Cholinesterase Inhibitors; Cognition Disorders; Depression; Double-Blind Method; Estrogens; Female; Humans; Male; Neurologic Examination; Psychiatric Status Rating Scales; Retrospective Studies; Sex Factors; Trichlorfon; Vitamin E | 2001 |
56 other study(ies) available for d-alpha tocopherol and Cognition Disorders
| Article | Year |
|---|---|
Micronutrients supplementation and nutritional status in cognitively impaired elderly persons: a two-month open label pilot study.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; beta Carotene; Carotenoids; Cognition Disorders; Dietary Supplements; Female; Folic Acid; Humans; Lutein; Male; Micronutrients; Middle Aged; Mouth Mucosa; Nutrition Assessment; Nutritional Status; Pilot Projects; Vitamin B Complex | 2013 |
Fructo-oligosaccharide improved brain β-amyloid, β-secretase, cognitive function, and plasma antioxidant levels in D-galactose-treated Balb/cJ mice.
Topics: alpha-Tocopherol; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Ascorbic Acid; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Galactose; Male; Mice; Mice, Inbred BALB C; Oligosaccharides | 2017 |
Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats.
Topics: Acetylcholinesterase; alpha-Tocopherol; Animals; Antioxidants; Brain; Catalase; Cognition Disorders; Dementia; Glutathione; Injections, Intraventricular; Lipid Peroxidation; Male; Maze Learning; Mitochondria; Motor Activity; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Reactive Nitrogen Species; Streptozocin; Superoxide Dismutase; Tocotrienols | 2009 |
High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects.
Topics: Aged; Aged, 80 and over; Aging; alpha-Tocopherol; Antioxidants; Biomarkers; Carotenoids; Chromatography, High Pressure Liquid; Cognition; Cognition Disorders; F2-Isoprostanes; Feeding Behavior; Female; Fruit; gamma-Tocopherol; Germany; Humans; Lycopene; Male; Micronutrients; Middle Aged; Oxidative Stress; Protein Carbonylation; Surveys and Questionnaires; Vegetables | 2009 |
α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome.
Topics: alpha-Tocopherol; Animals; Animals, Newborn; Brain; Cognition Disorders; Dinoprost; Disease Models, Animal; Down Syndrome; Fatty Acids, Unsaturated; Female; Free Radicals; Hippocampus; Hydroxycholesterols; Lipid Peroxidation; Maze Learning; Mice; Mice, Neurologic Mutants; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Space Perception | 2011 |
High-dose antioxidant supplements and cognitive function in community-dwelling elderly women.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Cognition; Cognition Disorders; Cohort Studies; Diet; Dietary Supplements; Female; Health Surveys; Humans; Logistic Models; Nurses; Risk; Telephone; Vitamin E | 2003 |
Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
Topics: Adolescent; Age Factors; alpha-Tocopherol; Analysis of Variance; Case-Control Studies; Child; Child Nutrition Disorders; Child, Preschool; Cognition Disorders; Cystic Fibrosis; Early Diagnosis; Humans; Infant; Infant, Newborn; Neonatal Screening; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Vitamin A; Vitamin E Deficiency; Wisconsin | 2005 |
[Predictors of diabetic encephalopathy].
Topics: Adult; alpha-Tocopherol; Blood Glucose; Brain Diseases, Metabolic; Cognition Disorders; Depressive Disorder; Diabetes Complications; Dietary Carbohydrates; Female; Humans; Male; Phospholipids; Predictive Value of Tests | 2006 |
Serum alpha-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Chicago; Cognition Disorders; Dietary Supplements; Female; Humans; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Statistics as Topic; Surveys and Questionnaires; Vitamin E; Women's Health | 2007 |
Effects of sulforaphane and vitamin E on cognitive disorder and oxidative damage in lead-exposed mice hippocampus at lactation.
Topics: Animals; Behavior, Animal; Body Weight; Cognition Disorders; Female; Hippocampus; Isothiocyanates; Lactation; Lead; Mice; Oxidative Stress; Sulfoxides; Superoxide Dismutase; Vitamin E | 2017 |
Diet and cognitive decline at middle age: the role of antioxidants.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Cognition; Cognition Disorders; Cohort Studies; Diet; Dietary Supplements; Feeding Behavior; Female; Flavonoids; Humans; Lignans; Lutein; Male; Middle Aged; Neuropsychological Tests; Surveys and Questionnaires; Vitamin E | 2015 |
Effects of vitamin E on lead-induced impairments in hippocampal synaptic plasticity.
Topics: Animals; Antioxidants; Cognition Disorders; Excitatory Postsynaptic Potentials; Hippocampus; Lead; Lipid Peroxidation; Male; Neuronal Plasticity; Rats; Rats, Wistar; Treatment Outcome; Vitamin E | 2015 |
Long-Term Vitamin E-Deficient Mice Exhibit Cognitive Dysfunction via Elevation of Brain Oxidation.
Topics: Animals; Antioxidants; Cerebral Cortex; Cholesterol; Cognition; Cognition Disorders; Hippocampus; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Vitamin E; Vitamin E Deficiency | 2015 |
Effect of vitamin E treatment on progressive cognitive impairment in a patient with adult-onset ataxia: a case report.
Topics: Age of Onset; Ataxia; Cerebellum; Cognition Disorders; Female; Humans; Middle Aged; Vitamin E; Vitamin E Deficiency; Vitamins | 2009 |
Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Erythrocytes; Female; Genotype; Glutathione Disulfide; Humans; Male; Neuropsychological Tests; Oxidative Stress; Severity of Illness Index; Vitamin E | 2008 |
Plasma tocopherols and the risk of cognitive impairment.
Topics: Cholesterol; Cognition Disorders; Data Interpretation, Statistical; Dementia; Humans; Lipids; Tocopherols; Vitamin E | 2008 |
Plasma urate and progression of mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Boston; Cognition Disorders; Confounding Factors, Epidemiologic; Dementia; Disease Progression; Donepezil; Female; Humans; Incidence; Indans; Male; Middle Aged; Nootropic Agents; Piperidines; Prevalence; Survival Analysis; Uric Acid; Vitamin E | 2009 |
Dietary fat intake and cognitive decline in women with type 2 diabetes.
Topics: Adult; Aged; Alcohol Drinking; Cognition Disorders; Diabetes Mellitus, Type 2; Dietary Fats; Dietary Supplements; Fatty Acids; Fatty Acids, Unsaturated; Follow-Up Studies; Humans; Life Style; Middle Aged; Nurses; Smoking; Surveys and Questionnaires; Vitamin E | 2009 |
Changes in vitamin E prescribing for Alzheimer patients.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Data Collection; Geriatric Psychiatry; Guideline Adherence; Heart Failure; Hospitalization; Humans; Incidence; Survival Rate; United States; Vitamin E | 2009 |
Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats.
Topics: Alzheimer Disease; Animals; Antioxidants; Avoidance Learning; Cerebral Cortex; Choline O-Acetyltransferase; Cognition Disorders; Disease Models, Animal; Drug Evaluation, Preclinical; Flavonoids; Glutathione; Hippocampus; Infusions, Intraventricular; Male; Maze Learning; Oxidative Stress; Plant Extracts; Protein Carbonylation; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Streptozocin; Thiobarbituric Acid Reactive Substances; Vitamin E | 2009 |
Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure.
Topics: Aluminum Chloride; Aluminum Compounds; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Blotting, Western; Chlorides; Cognition Disorders; Glucosides; Hippocampus; Male; Neuroprotective Agents; Neuropsychological Tests; Random Allocation; Rats; Rats, Sprague-Dawley; Stilbenes; Time Factors; Vitamin E; Vitamins | 2009 |
Vitamin E improves learning performance and changes the expression of nitric oxide-producing neurons in the brains of diabetic rats.
Topics: Animals; Anxiety; Brain; Cognition Disorders; Diabetes Mellitus, Experimental; Learning; Male; Maze Learning; Memory; Motor Activity; NADP; Neurons; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Vitamin E | 2010 |
Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Female; Follow-Up Studies; Genotype; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Vitamin E | 2010 |
Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance.
Topics: Aged; Aged, 80 and over; Cerebral Ventricles; Cognition; Cognition Disorders; Cohort Studies; Dementia; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Plaque, Amyloid; Psychomotor Performance; Vitamin E | 2011 |
Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Biomarkers; Cognition Disorders; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Oxidative Stress; Vitamin E | 2010 |
Antioxidants prevent memory deficits provoked by chronic variable stress in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain-Derived Neurotrophic Factor; Cognition Disorders; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Stress, Psychological; Vitamin E | 2011 |
Levothyroxine replacement therapy with vitamin E supplementation prevents oxidative stress and cognitive deficit in experimental hypothyroidism.
Topics: Animals; Cognition Disorders; Dietary Supplements; Disease Models, Animal; Hippocampus; Hormone Replacement Therapy; Hypothyroidism; Male; Malondialdehyde; Maze Learning; Oxidative Stress; Propylthiouracil; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thyroxine; Vitamin E | 2013 |
The association of antioxidants and cognition in the Nurses' Health Study.
Topics: Aged; Aging; Antioxidants; Ascorbic Acid; Carotenoids; Cognition Disorders; Female; Humans; Nurses; Vitamin E; Women's Health | 2013 |
Mind and memory supplement scorecard. Reliable evidence that supplements actually work is lacking, but exercise and a Mediterranean-style diet support healthy brain aging.
Topics: Aged; Aged, 80 and over; Aging; Antioxidants; Brain; Cognition Disorders; Diet, Mediterranean; Exercise; Female; Health Behavior; Health Status; Humans; Male; Memory Disorders; Middle Aged; Risk Reduction Behavior; Vitamin E | 2012 |
Vitamin E and cognitive decline in older persons.
Topics: Aged; Aged, 80 and over; Antioxidants; Carotenoids; Cognition; Cognition Disorders; Feeding Behavior; Female; Humans; Longitudinal Studies; Male; Population Surveillance; Psychological Tests; Vitamin A; Vitamin E | 2002 |
The Boyd Orr lecture. Nutrition interventions in aging and age-associated disease.
Topics: Activities of Daily Living; Aged; Aging; Antioxidants; Cardiovascular Diseases; Chronic Disease; Cognition Disorders; Energy Intake; Fruit; Humans; Neoplasms; Nutrition Disorders; Nutritional Requirements; Nutritional Status; Oxidative Stress; Risk Factors; Vegetables; Vitamin E | 2002 |
Good and bad news about vitamin E.
Topics: Cognition Disorders; Heart Diseases; Humans; Respiratory Tract Infections; Risk Factors; Vitamin E | 2002 |
Vitamin E treatment affects the progression of mild cognitive impairment to dementia.
Topics: Antioxidants; Cognition Disorders; Dementia; Disease Progression; Humans; Memory Disorders; Vitamin E | 2003 |
Folate and vitamin E deficiency impair cognitive performance in mice subjected to oxidative stress: differential impact on normal mice and mice lacking apolipoprotein E.
Topics: Aging; Animals; Apolipoproteins E; Cognition Disorders; Disease Models, Animal; Folic Acid; Folic Acid Deficiency; Genetic Predisposition to Disease; Maze Learning; Mice; Mice, Knockout; Neurodegenerative Diseases; Oxidative Stress; Vitamin E; Vitamin E Deficiency | 2003 |
Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury.
Topics: Amyloid; Amyloid beta-Peptides; Amyloidosis; Animals; Antioxidants; Brain; Brain Chemistry; Brain Concussion; Cognition Disorders; Dietary Supplements; Dinoprost; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Mice; Mice, Transgenic; Motor Activity; Oxidative Stress; Peptide Fragments; Vitamin E | 2004 |
Is antioxidant use protective of cognitive function in the community-dwelling elderly?
Topics: Age Factors; Aged; Antioxidants; Ascorbic Acid; Cognition; Cognition Disorders; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Oxidative Stress; Selenium; Sex Factors; Surveys and Questionnaires; Treatment Outcome; Vitamin A; Vitamin E; Zinc | 2003 |
Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Female; Geriatric Assessment; Humans; Logistic Models; Male; Mental Status Schedule; Netherlands; Odds Ratio; Population Surveillance; Prospective Studies; Statistics as Topic; Vitamin A; Vitamin E | 2005 |
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chromatography, High Pressure Liquid; Cognition Disorders; Cohort Studies; Confidence Intervals; Dementia; Female; Geriatric Assessment; Humans; Italy; Logistic Models; Male; Mental Status Schedule; Neuropsychological Tests; Odds Ratio; Population Surveillance; Prospective Studies; Vitamin E | 2005 |
Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Humans; Indans; Nootropic Agents; Piperidines; Treatment Failure; Vitamin E | 2005 |
Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia.
Topics: Aged; Antioxidants; Ascorbic Acid; Cognition Disorders; Dementia; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Population Surveillance; Prospective Studies; Vitamin E | 2005 |
Drug may temporarily slow progression of mild cognitive impairment.
Topics: Alzheimer Disease; Cognition Disorders; Donepezil; Female; Humans; Indans; Nootropic Agents; Piperidines; Vitamin E | 2005 |
Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats.
Topics: Age Factors; Aging; Analysis of Variance; Animals; Antioxidants; Avoidance Learning; Body Weight; Brain Chemistry; Cognition Disorders; Dietary Supplements; Glutathione; Male; Neuropsychological Tests; Oxidative Stress; Protein Carbonylation; Rats; Rats, Inbred Strains; Rats, Wistar; Superoxide Dismutase; Vitamin E | 2006 |
Results of vitamin E studies mixed.
Topics: Aged; Cardiac Output, Low; Cognition Disorders; Dietary Supplements; Female; Heart Diseases; Humans; Vitamin E | 2005 |
Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress.
Topics: Aging; Amyloid beta-Peptides; Animals; Apoptosis; Cell Death; Cognition Disorders; Hippocampus; Maze Learning; Oxidative Stress; Rats; Vitamin E; Vitamin E Deficiency | 2005 |
Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Female; Ginkgo biloba; Humans; Italy; Male; Middle Aged; Nootropic Agents; Practice Patterns, Physicians'; Surveys and Questionnaires; Vitamin E; Vitamins | 2006 |
Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
Topics: Aging; Alzheimer Disease; Antioxidants; Cognition Disorders; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidative Stress; Selegiline; Vitamin E | 2007 |
Antioxidants and prevention of cognitive decline: does duration of use matter?
Topics: Alzheimer Disease; Antioxidants; beta Carotene; Clinical Trials as Topic; Cognition Disorders; Humans; Time Factors; Treatment Outcome; Vitamin E | 2007 |
Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort.
Topics: Aged; Aged, 80 and over; Antioxidants; Cholesterol; Cognition Disorders; Cohort Studies; Confidence Intervals; Dementia; Disease Progression; Female; Humans; Incidence; Italy; Male; Multivariate Analysis; Odds Ratio; Prevalence; Risk Factors; Tocopherols; Vitamin E | 2008 |
Alcoholic cognitive deterioration and nutritional deficiencies.
Topics: Adult; Age Factors; Alcohol Drinking; Alcoholism; Blood Cell Count; Body Mass Index; Chromatography, Liquid; Cognition Disorders; Humans; Intelligence; Male; Middle Aged; Neuropsychological Tests; Nutrition Disorders; Nutritional Status; Space Perception; Visual Perception; Vitamin A; Vitamin E | 1994 |
The relation between antioxidants and memory performance in the old and very old.
Topics: Aged; Aging; Antioxidants; Ascorbic Acid; beta Carotene; Cognition Disorders; Cross-Sectional Studies; Female; Free Radicals; Humans; Longitudinal Studies; Male; Memory; Regression Analysis; Vitamin E; Wechsler Scales | 1997 |
Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du Vieillissement Artériel.
Topics: Aged; Aging; Antioxidants; Carotenoids; Cognition; Cognition Disorders; Female; France; Glutathione Peroxidase; Humans; Lipid Peroxidation; Longitudinal Studies; Male; Middle Aged; Oxidative Stress; Selenium; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 1998 |
Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits.
Topics: Aging; Animals; Antioxidants; Body Weight; Brain Chemistry; Calcium Radioisotopes; Cognition Disorders; Corpus Striatum; Diet; Dopamine; Eating; Electrophysiology; Fruit; gamma-Aminobutyric Acid; GTP Phosphohydrolases; Male; Norepinephrine; Purkinje Cells; Rats; Rats, Inbred F344; Reactive Oxygen Species; Signal Transduction; Spinacia oleracea; Synaptosomes; Time Factors; Vitamin E | 1998 |
Dietary antioxidant intake and cognitive performance in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study investigators.
Topics: Aged; Antioxidants; Ascorbic Acid; Carotenoids; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Dietary Supplements; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Surveys and Questionnaires; Vitamin E | 2000 |
Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel.
Topics: Aged; Aging; Antioxidants; Biomarkers; Carotenoids; Cognition Disorders; Erythrocytes; Female; France; Humans; Longitudinal Studies; Male; Mental Status Schedule; Oxidative Stress; Risk Factors; Selenium; Surveys and Questionnaires; Thiobarbituric Acid Reactive Substances; Vitamin E | 2000 |
Current and future treatments for cognitive deficits in dementia.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholinergic Agents; Cholinesterase Inhibitors; Cognition Disorders; Estrogens; Forecasting; Ginkgo biloba; Humans; Mental Health Services; Phytotherapy; Plants, Medicinal; Vitamin E | 2000 |
Medical utility of apoe allele determination in assessing the need for antioxidant therapy.
Topics: Alleles; Alzheimer Disease; Antioxidants; Apolipoprotein E4; Apolipoproteins E; Cognition Disorders; Coronary Disease; Genetic Predisposition to Disease; Humans; Models, Biological; Models, Genetic; Postoperative Complications; Stroke; Vitamin E | 2001 |